A man suffered a tragic, sudden accident and woke up paralyzed and with a breathing tube. Doctors asked him whether he wanted to continue living. Should they have waited?

Crystalloids have been the preferred agent for fluid resuscitation in the ICU, but a new study shows little difference between these and colloids in terms of 28-day mortality.

Under the leadership of Dr. Thomas Farley, New York City and Mayor Michael Bloomberg have implemented some of the toughest health laws in the nation.

Some doctors wonder whether it's wise to apologize if they've made an error. Bioethicist Art Caplan says it's a good idea, but you need to do it the right way.

Contrary to expectation, mortality and outcomes were the same with small segmental pulmonary embolism as with larger clots.

A 29-year-old Stanford dropout has developed a new biotechnology that threatens to give laboratory medicine its biggest shakeup in decades.

Clinical experience suggests that recently approved 4-factor prothrombin complex concentrate is superior to fresh frozen plasma in the management of warfarin-associated hemorrhage.

This thought-provoking study finds that a novel drug therapy may improve outcomes on in-hospital cardiac arrest.